Skip to main content
FDA: Puerto Rico disruptions could mean some drug shortages

The US may experience limited shortages of drugs as manufacturing facilities in Puerto Rico struggle with power and related hurricane damage, said FDA Commissioner Scott Gottlieb, and the shortages could involve around 40 drugs, including those for HIV, rheumatoid arthritis and cancer. Merck said it is operating with generator power, and Bristol-Myers Squibb and Amgen said they do not expect an impact on patient supplies.

Full Story: